A review of the current literature and a guide to the early diagnosis of autoimmune disorders associated with neuromyelitis optica

References

• Wingerchuk, D. M., V. A. Lennon, S. J. Pittock, et al. 2006. Revised diagnostic criteria for neuromyelitis optica. Neurology. 66: 1485–1489
   PubMed Web of Science ®Google Scholar
• Lennon, V. A. V., D. M. D. Wingerchuk, T. J. T. Kryzer, et al. 2004. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 364: 2106–2112
   PubMed Web of Science ®Google Scholar
• Haase, C. G., and S. Schmidt. 2001. Detection of brain-specific autoantibodies to myelin oligodendrocyte glycoprotein, S100beta and myelin basic protein in patients with Devic’s neuromyelitis optica. Neurosci. Lett. 307: 131–133
   PubMed Web of Science ®Google Scholar
• Kitley, J., M. Woodhall, P. Waters, et al. 2012. Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype. Neurology. 79: 1273–1277
   PubMed Web of Science ®Google Scholar
• Weinshenker, B. G. B., D. M. D. Wingerchuk, S. S. Vukusic, et al. 2006. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann. Neurol. 59: 566–569
   PubMed Web of Science ®Google Scholar
• Hoedemaekers, A. C. A., P. J. P. van Breda Vriesman, and M. H. M. De Baets. 1997. Myasthenia gravis as a prototype autoimmune receptor disease. Immunol. Res. 16: 341–354
   PubMed Web of Science ®Google Scholar
• Etemadifar, M., S.-H. Abtahi, A. Dehghani, et al. 2011. Myasthenia gravis during the course of neuromyelitis optica. Case Rep. Neurol. 3: 268–273
   PubMedGoogle Scholar
• Vaknin-Dembinsky, A., O. Abramsky, P. Petrou, et al. 2011. Myasthenia gravis-associated neuromyelitis optica-like disease: an immunological link between the central nervous system and muscle? Arch. Neurol. 68: 1557–1561
   PubMedGoogle Scholar
• Leite, M. I., E. Coutinho, M. Lana-Peixoto, et al. 2012. Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients. Neurology. 78: 1601–1607
   PubMed Web of Science ®Google Scholar
• Kister, I., S. Gulati, C. Boz, et al. 2006. Neuromyelitis optica in patients with myasthenia gravis who underwent thymectomy. Arch. Neurol. 63: 851–856
   PubMedGoogle Scholar
• Uzawa, A., M. Mori, Y. Iwai, et al. 2009. Association of anti-aquaporin-4 antibody-positive neuromyelitis optica with myasthenia gravis. J. Neurol. Sci. 287: 105–107
   PubMed Web of Science ®Google Scholar
• Antoine, J. C., J. P. Camdessanche, L. Absi, et al. 2004. Devic disease and thymoma with anti-central nervous system and antithymus antibodies. Neurology. 62: 978–980
   PubMed Web of Science ®Google Scholar
• Gotkine, M., Y. Fellig, and O. Abramsky. 2006. Occurrence of CNS demyelinating disease in patients with myasthenia gravis. Neurology. 67: 881–883
   PubMed Web of Science ®Google Scholar
• Furukawa, Y., H. Yoshikawa, A. Yachie, and M. Yamada. 2006. Neuromyelitis optica associated with myasthenia gravis: characteristic phenotype in Japanese population. Eur. J. Neurol. 13: 655–658
   PubMed Web of Science ®Google Scholar
• Nakamura, M., I. Nakashima, S. Sato, et al. 2007. Clinical and laboratory features of neuromyelitis optica with oligoclonal IgG bands. Mult. Scler. 13: 332–335
   PubMed Web of Science ®Google Scholar
• Bichuetti, D. B., T. M. de Barros, E. M. L. Oliveira, et al. 2008. Demyelinating disease in patients with myasthenia gravis. Arq. Neuropsiquiatr. 66: 5–7
   PubMed Web of Science ®Google Scholar
• Kay, C. S. K., R. H. Scola, P. J. Lorenzoni, et al. 2008. NMO-IgG positive neuromyelitis optica in a patient with myasthenia gravis but no thymectomy. J. Neurol. Sci. 275: 148–150
   PubMed Web of Science ®Google Scholar
• Isbister, C. M. C., P. J. P. Mackenzie, D. D. Anderson, et al. 2003. Co-occurrence of multiple sclerosis and myasthenia gravis in British Columbia. Mult. Scler. 9: 550–553
   PubMedGoogle Scholar
• Ikeda, K., Y. Araki, and Y. Iwasaki. 2007. Occurrence of CNS demyelinating disease in patients with myasthenia gravis. Neurology. 68: 1326 ; author reply 1327
   PubMedGoogle Scholar
• Ogaki, K., T. Hirayama, K. Chijiiwa, et al. 2012. Anti-aquaporin-4 antibody-positive definite neuromyelitis optica in a patient with thymectomy for myasthenia gravis. Neurologist. 18: 76–79
   PubMed Web of Science ®Google Scholar
• Jarius, S., K. P. Wandinger, K. Borowski, et al. 2012. Antibodies to CV2/CRMP5 in neuromyelitis optica-like disease: case report and review of the literature. Clin. Neurol. Neurosurg. 114: 331–335
   PubMed Web of Science ®Google Scholar
• Chan, K. H., J. S. C. Kwan, P. W. L. Ho, et al. 2010. Aquaporin-4 water channel expression by thymoma of patients with and without myasthenia gravis. J. Neuroimmunol. 227: 178–184
   PubMed Web of Science ®Google Scholar
• Jarius, S., F. Paul, D. Franciotta, et al. 2012. Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: ten new aquaporin-4 antibody positive cases and a review of the literature. Mult. Scler. J. 18: 1135–1143
   PubMed Web of Science ®Google Scholar
• Zifman, E., I. Litmanovitz, G. Segal, et al. 2010. Marked hypotonia in an infant of a mother with devic disease. J. Child Neurol. 25: 746–747
   PubMed Web of Science ®Google Scholar
• McKeon, A., V. A. Lennon, A. Jacob, et al. 2009. Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica. Muscle Nerve. 39: 87–90
   PubMed Web of Science ®Google Scholar
• Hadjivassiliou, M., D. S. Sanders, R. A. Grünewald, et al. 2010. Gluten sensitivity: from gut to brain. Lancet Neurol. 9: 318–330
   PubMed Web of Science ®Google Scholar
• McNamara, P. H., L. Costelloe, Y. Langan, and J. Redmond. 2010. Aquaporin-4 seropositivity in a patient with coeliac disease but normal neurological examination and imaging. J. Neurol. 258: 702–703
   PubMed Web of Science ®Google Scholar
• Jacob, S. 2005. Gluten sensitivity and neuromyelitis optica: two case reports. J. Neurol. Neurosurg. Psychiatry. 76: 1028–1030
   PubMed Web of Science ®Google Scholar
• Bergamaschi, R., S. Jarius, M. Robotti, et al. 2009. Two cases of benign neuromyelitis optica in patients with celiac disease. J. Neurol. 256: 2097–2099
   PubMedGoogle Scholar
• Matijaca, M., S. Pavelin, D. M. Kaliterna, et al. 2011. Pathogenic role of aquaporin antibodies in the development of neuromyelitis optica in a woman with celiac disease. Isr. Med. Assoc. J. 13: 182–184
   PubMed Web of Science ®Google Scholar
• Meyts, I., K. Jansen, M. Renard, et al. 2011. Neuromyelitis optica-IgG(+) optic neuritis associated with celiac disease and dysgammaglobulinemia: a role for tacrolimus? Eur. J. Paed. Neurol. 15: 265–267
   PubMed Web of Science ®Google Scholar
• Iyer, A., D. Rathnasabapathi, L. Elsone, et al. 2013. Transverse myelitis associated with an itcy rash and hyperCKemia: neuromyelitis optica associated with dermatitis herpetiformis. JAMA Neurol. Accepted for publication
   Web of Science ®Google Scholar
• Varrin-Doyer, M., C. M. Spencer, U. Schulze-Topphoff, et al. 2012. Aquaporin 4-specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize Clostridium ABC transporter. Ann. Neurol. 72: 53–64
   PubMed Web of Science ®Google Scholar
• Min, J., H. Kim, B. Kim, et al. 2009. Brain abnormalities in Sjogren syndrome with recurrent CNS manifestations: association with neuromyelitis optica. Mult. Scler. 15: 1069–1076
   PubMedGoogle Scholar
• Delalande, S. S., J. J. de Seze, A.-L. A. Fauchais, et al. 2004. Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Medicine (Abingdon). 83: 280–291
   Google Scholar
• Kim, S., P. Waters, A. Vincent, et al. 2009. Sjogren’s syndrome myelopathy: spinal cord involvement in Sjogren’s syndrome might be a manifestation of neuromyelitis optica. Mult. Scler. 15: 1062–1068
   PubMedGoogle Scholar
• Koga, S., K. Ikeda, D. Nakagomi, et al. 2011. A patient with neuromyelitis optica with positive anti-Ro (SS-A) antibody presenting with intractable hiccup and nausea. Mod. Rheumatol. 21: 561–562
   PubMed Web of Science ®Google Scholar
• Kahlenberg, J. M. 2011. Neuromyelitis optica spectrum disorder as an initial presentation of primary Sjögren’s syndrome. YSARH. 40: 343–348
   PubMed Web of Science ®Google Scholar
• Sofat, N. N., and P. J. P. Venables. 2008. Is Sjogren myelopathy Devic disease? Ann. Rheum. Dis. 67: 730–731
   PubMed Web of Science ®Google Scholar
• Gökçay, F., N. Çelebisoy, A. Gökçay, et al. 2007. Primary Sjögren’s syndrome presenting as neuromyelitis optica. Pediatr. Neurol. 36: 58–60
   PubMed Web of Science ®Google Scholar
• Barroso, B. 2007. Primary Sjögren’s syndrome mimicking neuromyelitis optica. Eur. J. Intern. Med. 18: 507–508
   PubMed Web of Science ®Google Scholar
• Arabshahi, B., A. N. Pollock, D. D. Sherry, et al. 2006. Devic disease in a child with primary Sjogren syndrome. J. Child Neurol. 21: 285–286
   PubMed Web of Science ®Google Scholar
• Mochizuki, A., A. Hayashi, S. Hisahara, and S. Shoji. 2000. Steroid-responsive Devic’s variant in Sjogren’s syndrome. Neurology. 54: 1391–1392
   PubMed Web of Science ®Google Scholar
• Pittock, S. J., V. A. Lennon, J. de Seze, et al. 2007. Neuromyelitis optica and non organ-specific autoimmunity. Arch. Neurol. 65: 78–83
   Google Scholar
• Kovacs, B., T. L. Lafferty, L. H. Brent, and R. J. DeHoratius. 2000. Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature. Ann. Rheum. Dis. 59: 120–124
   PubMed Web of Science ®Google Scholar
• Schulz, S. W., M. Shenin, A. Mehta, et al. 2011. Initial presentation of acute transverse myelitis in systemic lupus erythematosus: demographics, diagnosis, management and comparison to idiopathic cases. Rheumatol. Int. 32: 2623–2627
   PubMed Web of Science ®Google Scholar
• Birnbaum, J., and D. Kerr. 2007. Devic’s syndrome in a woman with systemic lupus erythematosus: diagnostic and therapeutic implications of testing for the neuromyelitis optica IgG autoantibody. Arthritis. Rheum. 57: 347–351
   PubMed Web of Science ®Google Scholar
• Birnbaum, J., and D. Kerr. 2008. Optic neuritis and recurrent myelitis in a woman with systemic lupus erythematosus. Nat. Clin. Pract. Rheumatol. 4: 381–386
   PubMedGoogle Scholar
• Ferreira, S. 2005. Devic's syndrome in systemic lupus erythematosus and probable antiphospholipid syndrome. Rheumatology. 44: 693–695
   PubMed Web of Science ®Google Scholar
• Birnbaum, J., M. Petri, R. Thompson, et al. 2009. Distinct subtypes of myelitis in systemic lupus erythematosus. Arthritis Rheum. 60: 3378–3387
   PubMed Web of Science ®Google Scholar
• Gibbs, A. N., J. Moroney, D. Foley-Nolan, and P. G. O’Connell. 2002. Neuromyelitis optica (Devic's syndrome) in systemic lupus erythematosus: a case report. Rheumatology (Oxford). 41: 470–471
   PubMed Web of Science ®Google Scholar
• Mehta, L. R., M. K. Samuelsson, A. K. Kleiner, et al. 2008. Neuromyelitis optica spectrum disorder in a patient with systemic lupus erythematosus and anti-phospholipid antibody syndrome. Multiple Sclerosis. 14: 425–427
   PubMedGoogle Scholar
• Nasir, S., D. A. Kerr, and J. Birnbaum. 2009. Nineteen episodes of recurrent myelitis in a woman with neuromyelitis optica and systemic lupus erythematosus. Arch. Neurol. 66: 1160–1163
   PubMedGoogle Scholar
• Pellkofer, H. L., R. Hohlfeld, and T. Kuempfel. 2010. Thirty-one episodes of myelitis and optic neuritis in a woman with neuromyelitis optica and systemic lupus erythematosus. Arch. Neurol. 67: 779–780; author reply 780
   PubMedGoogle Scholar
• Sergio, P., B. Mariana, O. Alberto, et al. 2010. Association of neuromyelitis optic (NMO) with autoimmune disorders: report of two cases and review of the literature. Clin. Rheumatol. 29: 1335–1338
   PubMed Web of Science ®Google Scholar
• Jacobi, C., K. Stingele, R. Kretz, et al. 2006. Neuromyelitis optica (Devic's syndrome) as first manifestation of systemic lupus erythematosus. Lupus. 15: 107–109
   PubMed Web of Science ®Google Scholar
• Polgár, A., C. Rózsa, V. Müller, et al. 2011. Devic’s syndrome and SLE. Autoimmun. Rev. 10: 171–174
   PubMed Web of Science ®Google Scholar
• Karim, S., and V. Majithia. 2009. Devic’s syndrome as initial presentation of systemic lupus erythematosus. Am. J. Med. Sci. 338: 245–247
   PubMed Web of Science ®Google Scholar
• Mahlios, J., A. K. De la Herrán-Arita, and E. Mignot. 2013. The autoimmune basis of narcolepsy. Curr. Opin. Neurobiol. 23: 767–773
   PubMed Web of Science ®Google Scholar
• Wijnans, L., C. Lecomte, C. de Vries, et al. 2013. The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns. Vaccine. 31: 1246–1254
   PubMed Web of Science ®Google Scholar
• Suzuki, K., T. Nakamura, K. Hashimoto, et al. 2012. Hypothermia, hypotension, hypersomnia, and obesity associated with hypothalamic lesions in a patient positive for the anti-aquaporin 4 antibody: a case report and literature review. Arch. Neurol. 69: 1355–1359
   PubMedGoogle Scholar
• Vernant, J. C., P. Cabre, D. Smadja, et al. 1997. Recurrent optic neuromyelitis with endocrinopathies: a new syndrome. Neurology. 48: 58–64
   PubMed Web of Science ®Google Scholar
• Petravić, D., M. Habek, S. Supe, and V. V. Brinar. 2006. Recurrent optic neuromyelitis with endocrinopathies: a new syndrome or just a coincidence? Mult. Scler. 12: 670–673
   PubMedGoogle Scholar
• Sekiguchi, T., S. Ishibashi, T. Kubodera, et al. 2011. Anhidrosis associated with hypothalamic lesions related to anti-aquaporin 4 autoantibody. J. Neurol. 258: 2293–2295
   PubMed Web of Science ®Google Scholar
• Viegas, S., A. Weir, M. Esiri, et al. 2009. Symptomatic, radiological and pathological involvement of the hypothalamus in neuromyelitis optica. J. Neurol. Neurosurg. Psychiatry. 80: 679–682
   PubMed Web of Science ®Google Scholar
• Nakajima, H., Y. Fujiki, T. Ito, et al. 2011. Anti-aquaporin-4 antibody-positive neuromyelitis optica presenting with syndrome of inappropriate antidiuretic hormone secretion as an initial manifestation. Case Rep. Neurol. 3: 263–267
   PubMedGoogle Scholar
• Baba, T., I. Nakashima, T. Kanbayashi, et al. 2009. Narcolepsy as an initial manifestation of neuromyelitis optica with antiaquaporin-4 antibody. J. Neurol. 256: 287–288
   PubMed Web of Science ®Google Scholar
• Kanbayashi, T., T. Shimohata, I. Nakashima, et al. 2009. Symptomatic narcolepsy in patients with neuromyelitis optica and multiple sclerosis: new neurochemical and immunological implications. Arch. Neurol. 66: 1563–1566
   PubMedGoogle Scholar
• Wingerchuk, D. M., W. F. Hogancamp, P. C. O’Brien, and B. G. Weinshenker. 1999. The clinical course of neuromyelitis optica (Devic’s syndrome). Neurology. 53: 1107–1114
   PubMed Web of Science ®Google Scholar
• Wingerchuk, D. M., and B. G. Weinshenker. 2012. The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease. Mult. Scler. J. 18: 5–10
   PubMed Web of Science ®Google Scholar
• Asgari, N., T. Owens, J. Frøkiaer, et al. 2010. Neuromyelitis optica (NMO) – an autoimmune disease of the central nervous system (CNS). Acta Neurologica Scandinavica. 123: 369–384
   PubMed Web of Science ®Google Scholar
• Komolafe, M. A., E. O. Komolafe, T. A., Sunmonu, et al. 2008. New onset neuromyelitis optica in a young Nigerian woman with possible antiphospholipid syndrome: a case report. J. Med. Case. Rep. 2: 348
   PubMedGoogle Scholar
• Salazar, R., M. Cerghet, E. Farhat, and H. W. Lim. 2012. Neuromyelitis optica in a patient with pemphigus foliaceus. J. Neurol. Sci. 319: 152–155
   PubMed Web of Science ®Google Scholar
• Elsone, L., T. Townsend, K. Mutch, et al. 2013. Neuropathic pruritus (itch) in neuromyelitis optica. Mult. Scler. J. 19: 475–479
   PubMed Web of Science ®Google Scholar
• Suzuki, N., T. Takahashi, M. Aoki, et al. 2010. Neuromyelitis optica preceded by hyperCKemia episode. Neurology. 74: 1543–1545
   PubMed Web of Science ®Google Scholar
• Saadoun, S., and M. C. Papadopoulos. 2013. Expression of AQP4 and complement regulators in human brain and peripheral organs: implications for NMO. Poster 733 ECTRIMS 2013, Copenhagen
   Google Scholar
• Pittock, S. J., and V. A. Lennon. 2008. Aquaporin-4 autoantibodies in a paraneoplastic context. Arch. Neurol. 65: 629–632
   PubMed Web of Science ®Google Scholar
• Santis, G., L. Caniatti, A. Vito, et al. 2009. A possible paraneoplastic neuromyelitis optica associated with lung cancer. Neurol. Sci. 30: 397–400
   PubMed Web of Science ®Google Scholar
• Mader, S., V. Gredler, K. Schanda, et al. 2011. Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders. J. Neuroinflammation. 8: 184
   PubMed Web of Science ®Google Scholar
• Honda, K., and T. Yuasa. 2008. A case of anti-aquaporin-4 and anti-glutamate receptor antibodies positive myelitis presented with modest clinical signs. Magn. Reson. Med. Sci. 7: 55–58
   PubMedGoogle Scholar